Objective: To determine the capillary partial pressure of carbon dioxide (PCO 2 ) and room air transcutaneous hemoglobin saturation (RA SAT) at 36 weeks' postmenstrual age (PMA) in infants born with weight between 501 and 1250 g.
Introduction
Chronic lung disease (CLD) affects approximately 40% of premature infants born between 501 and 1250 g. 1 A precise and accurate determination of CLD is important because this disorder is highly predictive of other neonatal morbidities, including growth and neurodevelopment. 2 There is wide variability in the rate of CLD among neonatal intensive care units (NICUs), suggesting that practice variation may contribute to the disorder. [3] [4] [5] Unfortunately, the accepted definition of CLD, any supplemental oxygen need at 36 weeks postmenstrual age (PMA) or discharge home (whichever first), is imprecise and subject to individual interpretation as to what constitutes a legitimate need for additional oxygen. 6 It has been proposed that lung injury in premature infants be referred to as bronchopulmonary dysplasia (BPD) rather than CLD in an attempt to clarify this disorder as distinct from other chronic lung diseases of infancy and childhood. 7 In addition, a more physiologic classification scheme of BPD has been offered as an alternative to the traditional CLD terminology in an effort to minimize the large differences in apparent lung injury rates caused by variation in supplemental oxygen use at 36 weeks PMA. 8 By having a clear physiologic requirement for oxygen at 36 weeks PMA, that is, a room air transcutaneous hemoglobin saturation (RA SAT) <90%, the incidence, severity and variation in BPD rates between NICUs should be accurately reflected and not dependent on a subjective determination of the disorder. 9 This concept is attractive, as such variation may obscure the important effects of various therapies tested in clinical trials.
As part of the Vermont Oxford Network (VON) NICU Quality Improvement Collaborative, participating NICUs have cooperatively endeavored to find and promote evidence-based potentially better practices (PBPs) that might reduce the incidence of CLD. 3, 10 We recognized the significant variation in CLD rates among NICUs, the imprecision of the definition and were perplexed at the variable impact of the implementation of PBPs on the incidence of CLD. We conducted a prospective evaluation of two measures of lung function in infants at high risk for lung injury, the resting capillary, partial pressure of carbon dioxide (PCO 2 ) and RA SAT. Our goal was to objectify and clarify the diagnosis of CLD and BPD in an attempt to refine the ability to determine which therapeutic strategies were affecting clinical outcomes.
Methods

Subjects
This investigation stemmed from a collaborative VON effort designed for member NICUs to study and select PBPs that might reduce the incidence of CLD. 3 As part of the group investigation, eight NICUs agreed to study a refined definition of CLD, which consisted of a RA SAT and PCO 2 determination at 36 weeks PMA. All NICUs were located at 2000 f or less above sea level. This was not a population-based study. Eligible infants were born with weight between 501 and 1250 g and were enrolled if their parents consented to the investigation as the infants approached 36 weeks PMA. Exclusion criteria included (a) congenital anomalies or genetic syndromes, (b) infants requiring mechanical ventilation or nasal continuous positive airway pressure (NCPAP) at 36 weeks PMA and/or (c) infants transferred to another NICU or death before 36 weeks PMA. PMA was determined using the multiple obstetric and neonatal criteria outlined in the VON Manual of Operations.
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Institutional Review Board approval was obtained at each hospital.
Room air saturation test
Testing was done within 72 h of 36 0/7 weeks PMA or discharge (whichever first) and was done at least 1 h after feeding while the infant was quiet and in the supine position. Baseline heart and respiratory rates were obtained and a pulse oximeter was placed on an extremity to obtain RA SAT. We did not require preductal oximetry since the chance of significant ductal shunting at 36 weeks PMA was quite small. Infants on supplemental oxygen then had their oxygen and nasal cannula removed and all infants had 12 consecutive 5-min averages of the room air saturation (60-min test). The average of the 12 readings was the infants' RA SAT. The test was aborted if the saturation persisted below 80%, if there was any significant apnea greater than 15 s or bradycardia less than 100 beats per min. There was no standardization of pulse oximeters to a single manufacturer across the eight NICUs.
PCO 2 test
Partial pressure of carbon dioxide (mm Hg) testing was done as a capillary blood draw on a warmed heel within 72 h of 36 0/7 weeks PMA or discharge (whichever first) and at least 1 h after feeding while the infant was quiet, not crying, and in the supine position. All NICUs used automated heel-stick devices (TenderfootF International Technidyne, Edison, NJ, or QuikheelFBecton Dickinson, Franklin Lakes, NJ). Infants on supplemental oxygen remained on such for the PCO 2 determination.
Definitions
Chronic lung disease was defined using the traditional description of any supplemental oxygen administration at 36 weeks PMA or discharge home (whichever first) with no stipulation as to the RA SAT (the VON definition). Room air nasal cannula use at 36 weeks was classified as No CLD. BPD classifications were determined using the Jobe-Bancalari definition 7 as modified by Walsh 8 and Ryan.
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No BPD was defined as no supplemental oxygen requirement at day 28 postnatal age and RA SAT at 36 weeks PMA or discharge (whichever first) >89%, Mild BPD as supplemental oxygen at day 28 postnatal age but RA SAT at 36 weeks PMA or discharge (whichever first) >89%, Moderate BPD as RA SAT <90% at 36 weeks PMA or discharge (whichever first) and Severe BPD as RA SAT <90% and supplemental oxygen need of 30% or more at 36 weeks PMA. Supplemental oxygen calculations for nasal cannulae were determined by using accepted conversion tables. 12 Radiographs and medications were not used in the classification of CLD or BPD.
Statistical analysis SPSS, Version 14 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. For analysis of group differences in PCO 2 and RA SAT, the univariate general linear model (GLM) procedure of SPSS was used. The equivalent of analysis of covariance was done because we used gender, PMA and weight at the time of PCO 2 and RA SAT testing as covariates in the GLM procedure. Trend analysis (linear contrast) was used with the GLM model, with an a level of 0.05 to see if PCO 2 increased with BPD severity.
Unlike PCO 2 (a normally distributed interval level variable), RA SAT is an ordinal level variable and so was transformed into ranks, with mean ranks used for ties. Ranks were used as the dependent measure in the GLM procedure. We also used rank transformations for covariate analysis (gender, PMA and weight at the time of testing). When group differences were found using the GLM procedure, post hoc tests for group differences were employed using t-tests for PCO 2 and Mann-Whitney U for RA SAT. The post hoc tests did not include covariates and were corrected for multiple testing by adjusting the a level downward to B0.008 using a Bonferroni adjustment.
Results
The eight participant NICUs were able to obtain consent for testing in 220 infants born between January 2004 and August 2005. Less than 3% of infants born with weight between 501 to 1250 g during the study period were ineligible because they required NCPAP or mechanical ventilation at 36 weeks PMA. Figure 1 illustrates that CLD and BPD are not synonymous. Because of the difference in their definitions, 74/157 (47%) of the No CLD infants, after determination of day 28 oxygen use and RA SAT evaluation, actually had BPD (principally Mild BPD). Similarly, 16/63 (25%) of CLD infants, after RA SAT evaluation, had values >89% (all Mild BPD). Tables 1 and 2 display relevant demographic and clinical descriptors for the CLD and BPD categories, respectively. Of note, the expected trend is that lung injured infants tend to be younger and lighter at birth, male and outborn. They also tend to have greater exposure to mechanical ventilation and supplemental oxygen and longer NICU length of stay. The single death was in the CLD or Moderate BPD group. Figure 2 depicts the relationship between PCO 2 and the CLD and BPD categories. Mean (s.d.) PCO 2 was significantly higher in the CLD compared to the No CLD group (54 (8) versus 45 (5) mm Hg, P<0.001) and significantly higher in the Moderate BPD compared to No BPD (54 (7) versus 45 (6) mm Hg, P<0.001) and significantly higher in the Moderate BPD compared to Mild BPD (54 (7) versus 47 (6) mm Hg, P<0.001). There was a significant linear trend for increasing PCO 2 with progression from No BPD through Severe BPD (P<0.01). Figure 3 depicts the median (range) results of the RA SAT evaluations when applied to the traditional CLD classification. One infant in the No CLD group had an RA SAT of <90% and 16/63 (25%) infants in the CLD group had an RA SAT >89%. No infants in the No CLD group had the RA SAT test aborted versus 33/63 (52%) aborted in the CLD group (RA SAT <80%). The median (range) RA SAT was significantly higher in the No CLD group compared to the CLD group (97% (88 to 100%) versus <80% (<80 to 95%), P<0.001). Figure 4 depicts the median (range) results of the RA SAT evaluations using the BPD classification. Only three infants were on room air nasal cannula at 36 weeks PMA, two were No BPD and one was Mild BPD. The RA SAT was significantly lower in the Mild BPD group compared to the No BPD group (95% (90 to 100%) versus 97% (91 to 100%), P<0.001). The RA SAT was significantly lower in the Moderate BPD group (<80% (<80 to 89%)) compared to the Mild BPD group (P<0.001) and to the No BPD group (P<0.001). The RA SAT for the Severe BPD group (all <80%) was less than the Mild BPD and No BPD groups (P<0.001). There was a significant linear trend for decreasing RA SAT with progression of No BPD through Severe BPD (P<0.001). Table 3 shows the correlation between PCO 2 and RA SAT versus pertinent NICU clinical variables. PCO 2 negatively correlated with gestational age and birth weight, and positively correlated with supplemental oxygen, NCPAP, and ventilator days, as well as total NICU days (P<0.01). In addition, male subjects had a significantly greater mean (s.d.) PCO 2 than female subjects (49(8) versus 46 mm Hg(7), P<0.05). RA SAT positively correlated with gestational age and birth weight and negatively correlated with supplemental oxygen, NCPAP, and ventilator days, as well as total NICU days (P<0.01). There was no significant difference in RA Figure 1 Assignment of infants to chronic lung disease (CLD) (supplemental oxygen at 36 weeks postmenstrual age) and bronchopulmonary dysplasia (BPD) (room air transcutaneous hemoglobin saturation test at 36 weeks postmenstrual age) groups. SAT between male and female subjects. PCO 2 and RA SAT negatively correlated with each other (P<0.01).
Discussion
To our knowledge, this investigation is the first to (a) report paired PCO 2 and RA SAT values at 36 weeks PMA in premature infants at high risk for CLD or BPD and (b) demonstrate how infants categorized as CLD or No CLD are reclassified as subtypes of BPD using the physiologic definition. [7] [8] [9] These data are important because the current definition of CLD (any supplemental oxygen at 36 weeks PMA) is imprecise since practitioners are not required to maintain uniform oxygenation and testing standards and inaccurate because there has been no general consensus as to what normal or desirable transcutaneous hemoglobin saturations should be in premature infants. 6 Furthermore, the present definitions of CLD and BPD are incomplete because only one component of lung function potentially affected by injury is evaluated, the ability to oxygenate hemoglobin.
Recent attempts at reducing the burden of CLD have met with mixed success. 3, 10, 13 As highlighted by Walsh, 8 one difficulty with quality improvement and application of important clinical trial findings is the lack of consensus as to what acceptable transcutaneous hemoglobin saturation ranges should be. A physiologic definition of BPD has been proposed that is attractive because of its relative simplicity and clarity. [7] [8] [9] No BPD denotes no supplemental oxygen at day 28 postnatal age and an RA SAT >89% at 36 weeks PMA. Mild BPD denotes a supplemental oxygen requirement at day 28 postnatal age but an RA SAT >89% at 36 weeks PMA. Moderate BPD denotes a supplemental oxygen requirement at day 28 postnatal age and an RA SAT <90% at 36 weeks PMA with an effective oxygen need <30%. Severe BPD denotes a supplemental oxygen requirement at day 28 postnatal age, an RA SAT <90% at 36 weeks PMA and an effective oxygen need X30%, or the need for NCPAP or mechanical ventilation. Applying this more objective definition has been shown to reduce the baseline institutional variation in BPD rates, as well as improve the ability to predict adverse pulmonary, growth and neurodevelopmental outcomes. 8, 14, 15 One of the important findings in the VON NICU Quality Improvement Collaborative was that the four NICUs that did not show a reduction in CLD after the adoption of several PBPs had baseline rates well below the VON CLD average of 40% in infants whose birth weights were 501 to 1250 g. 3 This particular observation stimulated the present investigation to try and answer an important question. If we have a more complete and objective definition of lung injury (PCO 2 and RA SAT), can we then more precisely and accurately monitor the effects of various respiratory practices on NICU outcomes? Perhaps NICUs that do not show absolute changes in conventional CLD rates would show differences in the rate or severity of BPD.
RA SAT determinations are well established as an objective marker of pulmonary function and newer, automated capillary heel-stick PCO 2 measurements have been shown to be accurate estimates of arterial PCO 2 . 16 We carefully standardized the PCO 2 measurements by making sure that the infants were at least 1 h post-feeding, quiet, comfortable, non-crying and with ready blood flow from a warmed heel. Thus, we reasoned these measurements (18) 16 (18) 2 (5) 
Outborn (%) 3 (4) 9 (10) 8 (18) to be reliable, straightforward, safe and relatively inexpensive. Infants born with birthweights between 501 and 1250 g who remain on mechanical ventilation or NCPAP at 36 weeks PMA are likely to have the most severe BPD. However, there were very few of these infants in our investigation (less than 3% of eligible infants) and they were excluded from the analysis because their RA SAT and PCO 2 could be altered by the positive pressure assistance given. This investigation in 220 infants born with weights 501 to 1250 g contains important findings. Sixteen of sixty-three (25%) of infants with traditionally defined CLD had RA SATs of 90% or above (Figure 3 ). One infant with No CLD had a RA SAT value of less than 90%. This confirms earlier observations of the misleading variability inherent in the current definition of CLD. 6, 8 Why individual infants with RA SAT 90% or above are placed in supplemental oxygen is unclear, but perhaps is related to feeding intolerance, apnea and/or a desire for higher saturations to support growth and development. There is little evidence to support such oxygen use and in fact, this practice may be harmful by increasing the risk of CLD and retinopathy of prematurity. 17, 18 We concur with others that the classification of lung injury in premature infants would be improved not only by indicating whether an infant requires supplemental oxygen at day 28 postnatal age and 36 weeks PMA but also by stipulating that a reasonable RA SAT that should trigger supplemental oxygen use is 89% or below. 8, 9 Our data suggest that increasing PCO 2 appears to be a reasonable marker of lung injury, whether it is defined as CLD or BPD. Although there is an overlap in individual measurements between classifications of lung injury, the trend is significant. More severe lung injury as defined by the CLD or BPD categories correlates with a higher PCO 2 ( Figure 2) . PCO 2 and RA SAT (a) negatively correlate with each other in a significant manner (Table 3 ) and (b) correlate equally with the single best predictor of CLD, gestational age (Table 3 ). In addition, a potential advantage to a PCO 2 measurement at 36 weeks PMA is that it provides an objective assessment of lung injury in those infants with more significant BPD who might not tolerate a RA SAT evaluation because of significant desaturation, 33/220 (15%) of our study infants (Figure 4 ).
Prior to this report, there were no broadly accepted normal values for PCO 2 in convalescent premature infants with or without CLD or BPD. Kovesi 19 obtained capillary PCO 2 measurements in a group of premature infants (obtained before discharge or shortly after as outpatients). The PMA of the infants at testing was not standardized, their definition of BPD was somewhat different from our investigation, and formal RA SAT testing was not done. Nevertheless, they were able to show a significant association between an elevated PCO 2 and the risk for subsequent adverse respiratory events such as readmission to the hospital and reintubation.
PCO 2 and RA SAT at 36 weeks PMA may be accurate markers of lung injury that could be used to select potentially better practices that reduce BPD. NICUs involved with multiple quality improvement projects designed to improve respiratory outcomes might benefit from objective definitions of BPD that can be trended over time. For example, the eight NICUs responsible for this investigation are currently conducting a 1-year corrected age telephone follow-up of the 220 study infants to determine if PCO 2 and/or RA SAT correlate with continuing respiratory morbidity.
Conclusion
A reasonable first step toward the rational analysis of clinical investigations and application of evidence-based practices related to the reduction of CLD would be the adoption of a more objective, physiologic definition of lung injury termed BPD. The RA SAT is a relatively simple measure of one important lung function and is a safe and practical parameter to obtain. We suggest that a PCO 2 measured near the time of RA SAT testing might also refine the definition of BPD, giving another objective measure of lung function that can be affected by premature birth and various NICU therapies. Comparison of standardized tests of oxygenation and ventilation between the treatment groups during clinical trials might lead toward rational therapies and allow more accurate comparison of pulmonary outcomes among NICUs which adopt potentially better practices to reduce lung injury. 
